Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.83B.
ENTERPRISE VALUE (EV)
$1.83B
Sarepta Therapeutics, Inc.
Market Cap
$1.80B
Enterprise Value (EV)
$1.83B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | $1.80B | $1.83B |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.81B | $1.97B |
| Novavax, Inc. (NVAX)vs › | $1.81B | $1.92B |
| Xencor, Inc. (XNCR)vs › | $1.78B | $1.80B |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | $2.41B |
| Generate Biomedicines, Inc. (GENB)vs › | $1.77B | $1.70B |
| Azenta, Inc. (AZTA)vs › | $1.84B | $1.71B |
| Absci Corporation (ABSI)vs › | $1.76B | $1.65B |
| Surgery Partners, Inc. (SGRY)vs › | $1.74B | $5.55B |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.87B | $1.68B |
Market Cap
$1.80B
Total Debt
$828.97M
Cash
$801.28M
Enterprise Value
$1.83B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
